Detalhe da pesquisa
1.
The changing landscape of small cell lung cancer.
Cancer
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470453
2.
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw
; 22(4): 249-274, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754467
3.
NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024.
J Natl Compr Canc Netw
; 22(2): 72-81, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503043
4.
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer.
Future Oncol
; 20(16): 1047-1055, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357801
5.
The biology and management of non-small cell lung cancer.
Nature
; 553(7689): 446-454, 2018 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29364287
6.
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(9): 961-979, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673108
7.
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
J Natl Compr Canc Netw
; 21(4): 340-350, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015337
8.
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(5): 497-530, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545176
9.
Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.
Future Oncol
; 18(24): 2639-2649, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35815644
10.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
J Natl Compr Canc Netw
; 19(3): 254-266, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668021
11.
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy.
Cancer
; 126(5): 1060-1067, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943168
12.
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.
Invest New Drugs
; 38(2): 457-467, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31065954
13.
Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer.
Future Oncol
; 16(12): 749-762, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228198
14.
Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014.
BMC Endocr Disord
; 20(1): 44, 2020 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32245472
15.
The expanding role of circulating tumor DNA in resectable non-small cell lung cancer.
Cancer
; 130(10): 1730-1732, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421941
16.
Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy.
Cancer
; 125(14): 2394-2399, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933354
17.
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer.
Br J Cancer
; 121(3): 211-217, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231122
18.
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).
Cancer
; 124(24): 4667-4675, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383906
19.
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
J Natl Compr Canc Netw
; 16(10): 1171-1182, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323087
20.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Lancet Oncol
; 18(1): 42-51, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932068